First Trust Dividend Strength ETF Stock Down 0.0 % FTDS opened at $52.09 on Wednesday. The company has a fifty day simple moving average of $50.76 and a 200 day simple moving average of $49.59 ...

Actinium Pharmaceuticals (NYSE:ATNM – Get Free Report) is one of 459 publicly-traded companies in the “Biotechnology” industry, but how does it weigh in compared to its competitors?

Equities researchers at Evercore ISI initiated coverage on shares of Portland General Electric (NYSE:POR – Get Free Report) in a research report issued on Wednesday, MarketBeat Ratings reports.

A number of research analysts have issued reports on MFA shares. Keefe, Bruyette & Woods raised their price target on shares of MFA Financial from $12.00 to $13.00 and gave the stock an ...

NYSE LLY opened at $924.89 on Wednesday. The company has a quick ratio of 0.87, a current ratio of 1.11 and a debt-to-equity ratio of 1.74. Eli Lilly and Company has a fifty-two week low of $516. ...

NovaGold Resources (TSE:NG – Get Free Report) is scheduled to issue its quarterly earnings data after the market closes on Wednesday, October 2nd. NovaGold Resources (TSE:NG – Get Free Report ...

Read Our Latest Report on NVDA NVIDIA Stock Performance Shares of NVDA stock opened at $120.87 on Wednesday. The firm has a 50-day moving average of $115.64 and a 200-day moving average of $107.64 ...

CrowdStrike Trading Down 1.6 % NASDAQ:CRWD opened at $288.54 on Wednesday. CrowdStrike Holdings, Inc. has a 52 week low of $157.59 and a 52 week high of $398.33. The stock has a market cap of $70. ...

The Goldman Sachs Group initiated coverage on shares of Avidity Biosciences (NASDAQ:RNA – Free Report) in a research note issued to investors on Tuesday morning, Marketbeat Ratings reports.

View Our Latest Analysis on VC Visteon Price Performance VC stock opened at $96.79 on Wednesday. Visteon Co. has a 1 year low of $88.37 and a 1 year high of $142.20. The company has a debt-to ...

Innovative Industrial Properties (NYSE:IIPR – Get Free Report) was upgraded by research analysts at Wolfe Research to a “hold” rating in a research report issued on Monday, Zacks.com reports.

Shares of Pfizer Inc. (NYSE:PFE – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the fifteen ratings firms that are covering the firm, Marketbeat.com reports.